David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jonathan Jenkins Ichikawa
Jack Alan Reynolds
Learn more about PhilPapers
Developing World Bioethics 13 (3):111-118 (2013)
The last 20 years have seen a staggering growth in the practice of off-shoring clinical research to low-and middle-income countries (LICs and MICs), a growth that has been matched by the neoliberal policies adopted by host countries towards attracting trials to their shores. A recurring concern in this context is the charge of exploitation, linked to various aspects of off-shoring. In this paper, I examine Alan Wertheimer's approach and offer an alternative view of understanding exploitation in this context. I will suggest that the justification for the enterprise of research is largely dependent on its integration within a health system from which participants regularly benefit and I argue that an attention to a principle of reciprocity will enable us to better recognize and address exploitation in international research
|Keywords||research ethics clinical trials developing world bioethics|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Danielle M. Wenner (2015). The Social Value of Knowledge and International Clinical Research. Developing World Bioethics 15 (2):76-84.
Similar books and articles
Angela Ballantyne (2008). Benefits to Research Subjects in International Trials: Do They Reduce Exploitation or Increase Undue Inducement? Developing World Bioethics 8 (3):178-191.
Gillian Nycum & Lynette Reid (2007). The Harm-Benefit Tradeoff in "Bad Deal" Trials. Kennedy Institute of Ethics Journal 17 (4):321-350.
Simon Woods & Pauline Mccormack (2013). Disputing the Ethics of Research: The Challenge From Bioethics and Patient Activism to the Interpretation of the Declaration of Helsinki in Clinical Trials. Bioethics 27 (5):243-250.
Margaret B. Liu (2010). A Clinical Trials Manual From the Duke Clinical Research Institute: Lessons From a Horse Named Jim. Wiley-Blackwell.
Alan Wertheimer (2010). Rethinking the Ethics of Clinical Research: Widening the Lens. Oxford University Press.
Bridget Pratt & Bebe Loff (2013). A Framework to Link International Clinical Research to the Promotion of Justice in Global Health. Bioethics 27 (3):387-396.
Jeremy Snyder (2012). Exploitations and Their Complications: The Necessity of Identifying the Multiple Forms of Exploitation in Pharmaceutical Trials. Bioethics 26 (5):251-258.
Danielle Laudy (2009). End of Life Pediatric Research: What About the Ethics? [REVIEW] Journal of Academic Ethics 7 (1-2):87-91.
Maurie Markman (2004). The Research Misconception. International Journal of Applied Philosophy 18 (2):241-252.
Ross E. G. Upshur (2008). Introduction. Journal of Academic Ethics 6 (4):271-275.
Douglas E. Schlichting (2010). Destabilizing the 'Equipoise' Framework in Clinical Trials: Prioritizing Non-Exploitation as an Ethical Framework in Clinical Research. Nursing Philosophy 11 (4):271-279.
Riekeder Graaf & Johannes J. M. Delden (forthcoming). On Using People Merely as a Means in Clinical Research. Bioethics.
Jeremy Sugarman (2004). Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials. Science and Engineering Ethics 10 (1):29-35.
Franklin G. Miller & Howard Brody (2007). Clinical Equipoise and the Incoherence of Research Ethics. Journal of Medicine and Philosophy 32 (2):151 – 165.
Added to index2012-06-19
Total downloads8 ( #470,950 of 1,932,507 )
Recent downloads (6 months)1 ( #456,270 of 1,932,507 )
How can I increase my downloads?